A Phase II study of anti–epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme - Concepedia

Concepedia

Publication | Closed Access

A Phase II study of anti–epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme

130

Citations

45

References

2010

Year

Linna Li, Tony S. Quang, Ed Gracely, Ji Hoon Kim, Jacqueline Emrich, Theodore E. Yaeger, Joseph M. Jenrette, Steven C. Cohen, Perry Black, Luther W. Brady

Journal of neurosurgery

Abstract

In this large Phase II study of 192 patients with GBM treated with anti-epidermal growth factor receptor (125)I-mAb 425 radioimmunotherapy, survival was 15.7 months, and treatment was safe and well tolerated.

References

	Year	Citations

Page 1